Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

CompletedOBSERVATIONAL
Enrollment

2,537

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Venous Thromboembolism
Trial Locations (12)

48202

Henry Ford Health System, Detroit

MA01805

Lahey Clinic, Burlington

B3H 1V7

Queen Elizabeth II Health Sciences Centre, Halifax

L8L 2X2

Hamilton General Hospital, Hamilton

L8V 1C3

Hamilton Health Sciences, Hamilton

N6A 4G5

London Health Sciences Centre, London

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

H3G 1A4

Montreal General Hospital, Montreal

H3T 1E2

Sir Mortimer B Davis Jewish General Hospital, Montreal

H3T 1M5

St. Mary's Hospital Centre, Montreal

H4J 1C5

Hopital du Sacre Coeur de Montreal, Montreal

0X3 7LJ

Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Hospital Research Institute

OTHER